N-aryl N′-hydroxyguanidines, a new class of NO-donors after selective oxidation by nitric oxide synthases:: Structure-activity relationship

被引:47
作者
Renodon-Cornière, A
Dijols, S
Perollier, C
Lefevre-Groboillot, D
Boucher, JL
Attias, R
Sari, MA
Stuehr, D
Mansuy, D
机构
[1] Univ Paris 05, Chim & Biochim Pharmacol & Toxicol Lab, CNRS, UMR 8601, F-75270 Paris 06, France
[2] Cleveland Clin Fdn, Lerner Res Fdn, Dept Immunol, Cleveland, OH 44195 USA
关键词
D O I
10.1021/jm011006h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The formation of nitric oxide (NO) was followed during the oxidation of 37 N-hydroxyguanidines or related derivatives, including 18 new N-aryl N'-hydroxyguanidines, by recombinant inducible nitric oxide synthase (NOS H). Several N-aryl N-hydroxyguanidines bearing a relatively small, electron-donating para subtituent, such as H, F, Cl, CH3, OH, OCH3, and NH2, led to NO formation rates between 8 and 41% of that of NO formation from the natural NOS substrate, N-omega-hydroxy-L-arginine (NOHA). The characteristics of these reactions were very similar to those previously reported for the oxidation of NOHA by NOS: W the strict requirement of NOS containing (6R)-5,6,7,8-tetrahydro-L-biopterin, reduced nicotinamide adenine dinucleotide phosphate, and 02 for the oxidation to occur, (ii) the formation of NO and the corresponding urea in a 1:1 molar ratio, and (iii) a strong inhibitory effect of the classical NOS inhibitors such as N-omega-nitro-L-arginine and S-ethyl-iso-thiourea. Structure-activity relationship studies showed that two structural factors are crucial for NO formation from compounds containing a C=NOH function. The first one is the presence of a monosubstituted N-hydroxyguanidine function, since disubstituted N-hydroxyguanidines, amidoximes, ketoximes, and aldoximes failed to produce NO. The second one is the presence of a N-phenyl ring bearing a relatively small, not electron-withdrawing para substituent that could favorably interact with a hydrophobic cavity close to the NOS catalytic site. The k(cat) value for NOS II-catalyzed oxidation of N-para-fluorophenyl N'-hydroxyguanidine was 80% of that found for NOHA, and its k(cat)/K-m. value was only 9-fold lower than that of NOHA. Interestingly, the K,,, value found for NOS II-catalyzed oxidation of N-(-3-thienyl) N'-hydroxyguanidine was 25 muM, almost identical to that of NOHA. Recombinant NOS I and NOS M also oxidize several N-aryl N-hydroxyguanidines with the formation of NO, with a clearly different substrate specificity. The best substrates of the studied series for NOS I and NOS III were N-(para-hydroxyphenyl) and N-(meta-aminoplienyl) N'-hydroxyguanidine, respectively. Among the studied compounds, the para-chloroplienyl and para-methylphenyl derivatives were selective substrates of NOS II. These results open the way toward a new class of selective NO donors after in situ oxidation by each NOS family.
引用
收藏
页码:944 / 954
页数:11
相关论文
共 67 条
[1]   Analysis of neuronal NO synthase under single-turnover conditions: Conversion of N-omega-hydroxyarginine to nitric oxide and citrulline [J].
AbuSoud, HM ;
Presta, A ;
Mayer, B ;
Stuehr, DJ .
BIOCHEMISTRY, 1997, 36 (36) :10811-10816
[2]   Asymmetric synthesis of conformationally restricted L-arginine analogues as active site probes of nitric oxide synthase [J].
Atkinson, RN ;
Moore, L ;
Tobin, J ;
King, SB .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (10) :3467-3475
[3]   Design of isoform-selective inhibitors of nitric oxide synthase [J].
Babu, BR ;
Griffith, OW .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :491-500
[4]   HYDROXYGUANIDINES - NEW CLASS OF ANTIHYPERTENSIVE AGENTS [J].
BAILEY, DM ;
DEGRAZIA, CG ;
LAPE, HE ;
FRERING, R ;
FORT, D ;
SKULAN, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) :151-156
[5]   AN EASY SYNTHESIS OF 3-AMINOTHIOPHENE AND 3-NITROTHIOPHENE [J].
BARKER, JM ;
HUDDLESTON, PR ;
WOOD, ML .
SYNTHETIC COMMUNICATIONS, 1995, 25 (23) :3729-3734
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE [J].
BREDT, DS ;
HWANG, PM ;
GLATT, CE ;
LOWENSTEIN, C ;
REED, RR ;
SNYDER, SH .
NATURE, 1991, 351 (6329) :714-718
[8]   SYNTHESES AND STEREOCHEMISTRY OF AMIDOXIMES [J].
BUSHEY, DF ;
HOOVER, FC .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (21) :4198-4206
[9]   CYTOCHROME-P450 DEPENDENT N-HYDROXYLATION OF A GUANIDINE (DEBRISOQUINE), MICROSOMAL CATALYZED REDUCTION AND FURTHER OXIDATION OF THE N-HYDROXY-GUANIDINE METABOLITE TO THE UREA DERIVATIVE - SIMILARITY WITH THE OXIDATION OF ARGININE TO CITRULLINE AND NITRIC-OXIDE [J].
CLEMENT, B ;
SCHULTZEMOSGAU, MH ;
WOHLERS, H .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (12) :2249-2267
[10]   N-phenylamidines as selective inhibitors of human neuronal nitric oxide synthase:: Structure-activity studies and demonstration of in vivo activity [J].
Collins, JL ;
Shearer, BG ;
Oplinger, JA ;
Lee, SL ;
Garvey, EP ;
Salter, M ;
Duffy, C ;
Burnette, TC ;
Furfine, ES .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2858-2871